Guardant Health stock has had several attempts at breaking out of a cup base. The company has a blood test to detect colon cancer.

Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost ...

Cardiff Oncology (CRDF) is a speculative buy with potential blockbuster gains ahead of its 2026 data readout. Read here for ...

Guardant Health, Inc. shows strong adoption and revenue growth in oncology and data. Click for my updated look at GH stock ...

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...

New Data Highlight Continued Potential of Radspherin to Prevent Disease Progression OSLO, Norway, Oct. 8, 2025 /PRNewswire/ -- Oncoinvent ASA, a clinical-stage ...

A global study has found six types of cancer are on the rise in young people aged between 20 and 49 years old. Some 20 ...

Cancer Immunotherapy Market Cancer Immunotherapy Market Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 ...

Mail-in stool kits such as Colorguard can detect warning signs, but gastroenterologists say a colonoscopy is still the most ...

Katreena Davis of Georgia CORE discusses the troubling rise of colon cancer in young people and Black people, in particular.

Rates of colorectal cancer are rising, especially for people younger than 50. But it's hard to raise awareness for a cancer that a lot of us find hard to talk about.